Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 37 (5) , 297.e9-297.e17
Abstract
No abstract availableKeywords
Funding Information
- Ontario (10Nov-412)
- Institute of Cancer Research
- Prostate Cancer Canada (2011-700, 2014-01)
This publication has 45 references indexed in Scilit:
- Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated HypoxiaPLOS ONE, 2013
- Genome-wide promoter methylation profile of human testis and epididymis: identified from cell-free seminal DNABMC Genomics, 2013
- Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate CancerInternational Journal of Molecular Sciences, 2013
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Changes in circulating microRNA levels associated with prostate cancerBritish Journal of Cancer, 2012
- A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen RangeJournal of Urology, 2011
- Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer PatientsCancer Research, 2011
- Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progressionInternational Journal of Cancer, 2011
- Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate CancerJAMA, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009